Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 May;50(5):958-64.
doi: 10.1002/pbc.21447.

Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997

R Beverly Raney  1 , Murali Chintagumpala, James Anderson, Alberto Pappo, Stephen Qualman, Moody Wharam, Eugene Wiener, William Meyer; Soft-Tissue Sarcoma Committee of the Children's Oncology Group, Arcadia, California
Affiliations
Clinical Trial

Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997

R Beverly Raney et al. Pediatr Blood Cancer. 2008 May.

Abstract

Purpose: We analyzed the outcome of 47 patients with superficial facial rhabdomyosarcoma (RMS) treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-III, -IV-Pilot, and -IV.

Methods: We reviewed patients' records. Clinico-pathologic features, treatment, and outcome were examined to identify prognostic factors.

Results: Thirty-two patients were males; 35 patients were 1-9 years old at diagnosis. Tumor sites were buccal/cheek (N = 21), external nasal/nasolabial (N = 12), lip/chin (N = 9), and masseter (N = 5). Patients (46/47) had localized disease: 18 biopsy only (Group III), 17 microscopic residual tumor (Group II), and 11 complete resection without residual tumor (Group I). Eight-year estimated event-free survival (EFS) and overall survival (OAS) rates were 61% and 65%. Patients <12 months old had inferior EFS, 21%, compared to approximately 68% in older patients (P = 0.077). Eight-year EFS rates were 80% for females and 50% for males (P = 0.096). Eight-year EFS rates were 72% in 33 patients without regional lymph-nodal tumor and 39% in 14 patients with regional nodal tumor (P = 0.07). Eight-year EFS rates were 72% for 22 patients with embryonal RMS and 53% for 23 patients with alveolar RMS (P = 0.28). Location of the primary tumor was not significantly related to outcome.

Conclusions: Patients with superficial facial RMS often have localized, grossly resectable lesions at the time of presentation. Favorable prognostic factors include age >12 months, female gender, embryonal histology, and no lymph-nodal tumor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Event-free survival (EFS) and overall survival (OAS) in 47 patients with superficial facial rhabdomyosarcoma.
Fig. 2
Fig. 2
Event-free survival of patients by gender.
Fig. 3
Fig. 3
Event-free survival by regional lymph node status at diagnosis.
Fig. 4
Fig. 4
Event-free survival of patients with embryonal RMS versus alveolar RMS.
See this image and copyright information in PMC

References

    1. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. 1988:209–220. - PubMed
    1. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71:1904–1922. - PubMed
    1. Crist WM, Raney RB, Ragab A, et al. Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas. Med Pediatr Oncol. 1987;15:51–57. - PubMed
    1. Crist W, Gehan EA, Ragab AH, et al. The Third Inter-group Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610–630. - PubMed
    1. Ortega JA, Ragab AH, Gehan EA, et al. A feasibility, toxicity, and efficacy study of ifosfamide, actinomycin D, and vincristine for the treatment of childhood rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Study IV Pilot Study. Am J Pediatr Hematol/Oncol. 1993;15:S15–S20.

Publication types

MeSH terms